HMOX1 and glioblastoma: Although hybrids 1–4 showed only moderate antiproliferative activity against glioblastoma cells, we proved for the first time that simultaneously targeting HO-1 and σR proteins reduces DU145 and U87MG cell proliferation to a major extent concerning the effect achieved with single compounds.